GB Meka
Stocks to watch

ENSG

Compare

ENSIGN GROUP INC · Healthcare

$173.12
▼ 1.4%Close 2026-09-30

Live intraday price

Compare with our price levels

T2185.40
T1181.68
E1171.87
E3162.28
SL158.68

Close 2026-09-30: $173.12 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Near buy zone• Neutral

Near the buy zone — 0.7% above the first entry · 2 whales recently bought

1 month
▲ 0.5%
3 months
▲ 5.0%
1 year
▲ 1.1%
Analyst target
$220.00 +27.1%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$171.87 -0.7%
E2$167.23 -3.4%
E3$162.28 -6.3%
Targets
T1$181.68 4.9%
T2$185.40 7.1%
T3$188.92 9.1%
Stop-loss
SL$158.68 -8.3%
Whale cost ~$162.28 -6.3%

Risk : reward 1 : 2.2Moves ~$3.60 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 2 ราย
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 220.00 (upside +27%, 5 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
  • ●รายได้โต +17% เทียบปีก่อน
! Risks (3)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Mario Gabelli (ลด)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -33% ใน 6 เดือน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Blouin Ann Scott · Director

2026-07-27 · 200 shares @ $185.00 · pre-planned sale (10b5-1)

$37,000
Sell

Blouin Ann Scott · Director

2026-07-27 · 175 shares @ $181.88 · pre-planned sale (10b5-1)

$31,829
Sell

Agwunobi John O · Director

2026-07-20 · 392 shares @ $171.06 · pre-planned sale (10b5-1)

$67,056
Sell

Parkinson Mark Vincent · Director

2026-07-16 · 100 shares @ $168.12 · pre-planned sale (10b5-1)

$16,812
Sell

SMITH BARRY M · Director

2026-06-02 · 700 shares @ $164.28 · pre-planned sale (10b5-1)

$114,996
Sell

SMITH BARRY M · Director

2026-05-04 · 700 shares @ $182.21 · pre-planned sale (10b5-1)

$127,547
Sell

Agwunobi John O · Director

2026-04-20 · 392 shares @ $199.97 · pre-planned sale (10b5-1)

$78,388
Sell

Parkinson Mark Vincent · Director

2026-04-16 · 100 shares @ $196.60 · pre-planned sale (10b5-1)

$19,660
Sell

SMITH BARRY M · Director

2026-04-02 · 700 shares @ $196.65 · pre-planned sale (10b5-1)

$137,655
Sell

SMITH BARRY M · Director

2026-03-02 · 700 shares @ $213.02 · pre-planned sale (10b5-1)

$149,114
Sell

Uychiat Pison Marivic · Director

2026-02-20 · 67 shares @ $204.92 · pre-planned sale (10b5-1)

$13,730
Sell

Wittekind Beverly B. · Officer

2026-02-19 · 500 shares @ $210.23 · pre-planned sale (10b5-1)

$105,115
Sell

Uychiat Pison Marivic · Director

2026-02-19 · 83 shares @ $211.02 · pre-planned sale (10b5-1)

$17,514
Sell

Shaw Daren · Director

2026-02-17 · 1,000 shares @ $213.43 · pre-planned sale (10b5-1)

$213,430
Sell

Blouin Ann Scott · Director

2026-02-09 · 375 shares @ $198.00 · pre-planned sale (10b5-1)

$74,250

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-27In line +4%

Actual EPS $1.92 · est. $1.85 · Before open

▲ 2.9%

Day 1

+0.7%

Next 20 days

2026-04-30In line +2%

Actual EPS $1.85 · est. $1.82 · After close

▼ 1.6%

Day 1

-10.2%

Next 20 days

2026-02-04In line +3%

Actual EPS $1.82 · est. $1.77 · After close

▲ 13.8%

Day 1

+5.1%

Next 20 days

2025-11-03In line +2%

Actual EPS $1.64 · est. $1.61 · After close

▲ 0.1%

Day 1

-2.7%

Next 20 days

2025-07-24In line +3%

Actual EPS $1.59 · est. $1.55 · After close

▲ 8.9%

Day 1

+14.9%

Next 20 days

2025-04-29Miss -8%

Actual EPS $1.37 · est. $1.49 · After close

▲ 0.7%

Day 1

+13.6%

Next 20 days

2025-02-05In line +1%

Actual EPS $1.49 · est. $1.48 · After close

▼ 8.7%

Day 1

-4.1%

Next 20 days

2024-10-24In line +1%

Actual EPS $1.39 · est. $1.38 · After close

▲ 2.7%

Day 1

-4.2%

Next 20 days

Listen to the earnings call or read the full report on ENSG's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$10.1B
Next earnings2026-11-03
P/E (price to earnings)27.1
Forward P/E (on expected earnings)20.2
Revenue growth (YoY)+17.3%
Earnings growth (YoY)+16.7%
Net profit margin+6.9%
ROE+17.0%
Debt to equity (D/E)92%
Dividend yield15.00%
Analyst targets (high / low)$230.00 / $207.00
Number of analysts5
Trend and technical indicators
Trend short / mid / longSideways → · Sideways → · Downtrend ↘
RSI46
MA50 / MA200$176.62 / $181.77
Distance from MA200-4.8%
MACDPositive
1-year high / low$217.84 / $141.52
vs. S&P 500 (6 months)-32.8%
Volume vs. average0.12×